Emerging evidence
Published recordHealthGeneral
More
Profluent And BioMarin Pharmaceutical Inc. Partner To Design Novel Medicines Using AI
- Truvace record
- TRV-2026-1229raw data (JSON)
- Version
- v3Revised
- First published
- Evidence type
- News report
- Sources
- 1 sourceJournalism
- sha256
- 46339b270885…check it
Profluent announced a collaboration with BioMarin Pharmaceutical Inc. to design and optimize novel enzyme therapies for BioMarin's pipeline. Under the agreement, Profluent will apply its foundational...
The gain
Profluent will use its AI platform to design and optimize novel enzyme therapies for BioMarin's drug pipeline under a new collaboration.
Sources
1 on file- MarketScreenermarketscreener.com
Cite this record
v3Truvace Impact Record TRV-2026-1229, v3: “Profluent And BioMarin Pharmaceutical Inc. Partner To Design Novel Medicines Using AI.” Truvace, 2026-11-04. /record/TRV-2026-1229 (accessed on the day you copy it). sha256 46339b270885b83b…
Change history
3 versionsEvery change made to this record since it was first published, and why.
Copy cleanup: removed remarks about truncated source text.
Direction audit: the gain line stated no AI consequence and was removed. Filed as context; not counted as a gain or a problem.
Certified into the record
Check this record hasn’t been altered
How to check it yourself, without trusting this page
Download any version from /api/record/TRV-2026-1229 and hash its canonical field yourself, for example with shasum -a 256. You should get its content_hash. Each version’s text also ends with prev:and the hash of the version before it (version 1 points to 64 zeros). If anyone had changed a single character of any version after it was saved, those hashes wouldn’t line up.
ace